Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Invested Capital (2018 - 2025)

Health Catalyst (HCAT) has disclosed Invested Capital for 8 consecutive years, with $485.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Invested Capital fell 30.71% year-over-year to $485.1 million, compared with a TTM value of $485.1 million through Sep 2025, down 30.71%, and an annual FY2024 reading of $747.6 million, up 25.65% over the prior year.
  • Invested Capital was $485.1 million for Q3 2025 at Health Catalyst, down from $500.6 million in the prior quarter.
  • Across five years, Invested Capital topped out at $759.7 million in Q1 2025 and bottomed at $425.0 million in Q4 2022.
  • Average Invested Capital over 5 years is $612.2 million, with a median of $617.1 million recorded in 2023.
  • The sharpest move saw Invested Capital soared 112.66% in 2021, then crashed 39.55% in 2022.
  • Year by year, Invested Capital stood at $703.0 million in 2021, then crashed by 39.55% to $425.0 million in 2022, then surged by 39.99% to $595.0 million in 2023, then rose by 25.65% to $747.6 million in 2024, then plummeted by 35.11% to $485.1 million in 2025.
  • Business Quant data shows Invested Capital for HCAT at $485.1 million in Q3 2025, $500.6 million in Q2 2025, and $759.7 million in Q1 2025.